ONCOLOGY's reply to my initial complaint about the manuscript rejection. The manuscript was apparently sent (for the first time, it appears) for a formal, written review, by an annonymous reviewer (review follows):

November 29, 2001

Larry M. Weisenthal, MD, PhD
Weisenthal Cancer Group
15140 Transistor Lane
Huntington Beach, CA 92649

Dear Larry:

Well, I submitted your manuscript to the editorial review board for further consideration, and their judgement remains that the science just doesn't support the clinical recommendations. We are returning your manuscript herewith. The enclosed comments from one reviewer pretty well summarize the consensus review.

I apologize again, Larry, about this mix up. We will, of course, send you the promised honorarium, though I know that was not your motivation for undertaking the article. If you would care to submit the manuscript elsewhere, you might want to consider Cancer Investigation. It is edited by Yashar Hirshaut and Joe Bertino.

You should send the manuscript to Dr. Hirshaut at:

Cancer Investigation
Room 1508
2495 Amsterdam Avenue
New York, NY 10033

Sincerely yours,

James F. McCarthy Senior Vice President, Editorial